IBS - Irritable Bowel Syndrome Clinical Trial
Official title:
Ashtangayoga for IBS Show Positive Preliminary Effects on Symptoms and Well-being in an Uncontrolled Pilot Study
The study aims to test the effect of Ashtanga yoga on well-being in patients with irritable bowel syndrome (IBS). The intervention comprises group sessions on the Ashtanga school of yoga. Participants are recruited from primary care and measurements on well-being and IBS symptoms are conducted at pre-treatment, post-treatment and 6-month follow-up.
The intervention comprises participants with IBS to undergo Ashtanga yoga sessions in a group led by an authorized yoga teacher for a total period of 10 weeks. The first 4 weeks consisted of 1 session/week and the following 6 weeks consisted of 1 session/2 weeks. All movements and exercises are performed based on the individual's personal capacity in order to avoid distinct discomfort or pain. Patients testing positive for IBS will be recruited for the study from primary care. Measurements of IBS symptoms, visceral sensitivity, extraintestinal symptoms and quality of life will be assessed at pre-treatment, post-treatment and 6-month follow-up. Specific statistical methods will be performed to assess changes from pre- to post-treatments and changes from post-treatment to 6-month-follow-up. Effects sizes for within group changes will also be calculated. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05118243 -
Innovative Tools to Produce Legume-based Foods for Increased Consumer Acceptance
|
N/A | |
| Completed |
NCT04422327 -
The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05178017 -
Lifestyle Eating and Performance (LEAP) Program for the Treatment of Irritable Bowel Syndrome (IBS)
|
N/A | |
| Completed |
NCT05197413 -
Study to Evaluate the Efficacy of Arrae's Bloat & Calm Alchemy Capsules to Reduce Bloating, Heartburn and Gas, and Alleviate the Intensity of IBS Symptoms
|
N/A | |
| Completed |
NCT04905524 -
Activity Changes in Irritable Bowel Syndrome (IBS), Anxiety, and Depression Following the Use of Viome Precision Nutrition Program (VPNP)
|
N/A | |
| Recruiting |
NCT06297785 -
Online, Gut-directed Hypnotherapy for Patients With Irritable Bowel Syndrome (IBS)
|
N/A | |
| Recruiting |
NCT05874830 -
The Optimal Route of Fecal Microbiota Transplantation for Irritable Bowel Syndrome
|
N/A | |
| Active, not recruiting |
NCT04723056 -
Zemedy Application for Irritable Bowel Syndrome
|
N/A | |
| Completed |
NCT05565612 -
Clinical Trial to Evaluate the Effect of a Probiotic Mixture on Signs and Symptoms of Irritable Bowel Syndrome
|
N/A | |
| Recruiting |
NCT03131414 -
The IMAGINE-SPOR CIHR Chronic Disease Network
|
||
| Completed |
NCT03333291 -
Fecal Transplantation in Patients With IBS
|
N/A | |
| Completed |
NCT03449628 -
L. Casei DG® in Patients With Irritable Bowel Syndrome.
|
N/A | |
| Recruiting |
NCT06215222 -
Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease
|
||
| Completed |
NCT05016596 -
Postprandial Lipids in IBS and Nutritional Treatment
|
N/A | |
| Recruiting |
NCT04760353 -
The Effect of a Probiotic Mixture in Obese Patients With Irritable Bowel Syndrome
|
N/A | |
| Recruiting |
NCT04217733 -
Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome
|
Phase 3 | |
| Completed |
NCT03178877 -
The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors
|
N/A | |
| Recruiting |
NCT05990764 -
Effects of a Combination of Polyphenol-rich Extracts, Prebiotics, and Hydrolyzed Fiber on the Quality of Life of Patients With Irritable Bowel Syndrome (IBS)
|
N/A | |
| Completed |
NCT03948854 -
Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients
|
N/A | |
| Completed |
NCT04898257 -
Effect of Lactibiane Tolerance® to Treat Leaky Gut in Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)Patients
|
N/A |